Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.

RS, Sperling; DE, Shapiro; GD, McSherry; P, Britto; BE, Cunningham; M, Culnane; RW, Coombs; G, Scott; Dyke RB, Van; WT, Shearer; E, Jimenez; C, Diaz; DD, Harrison; JF, Delfraissy

doi:10.1097/00002030-199814000-00012

Public

Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.

Shared by NobleBlocks on Oct 1, 1998 • 12:00 AM UTC

Authors:

Sperling RS

Shapiro DE

McSherry GD

Abstract

Objective To determine the safety of the zidovudine (ZDV) regimen utilized in the Pediatric AIDS Clinical Trial Group (ACTG) 076 study.Design ACTG 076 was a randomized, double-blind, placebo-controlled trial which demonstrated that a ZDV regimen could prevent mother-to-child HIV-1 transmission. Infa...

Discussions